Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !
Ga offline met de app Player FM !
Graft Polymer UK CEO discusses strong progress in Awakn Life Sciences collaboration
MP3•Thuis aflevering
Manage episode 436624057 series 2891889
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences. Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). He noted that Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development. These compounds show promise in improving treatment options for conditions like PTSD, which affects millions globally. Additionally, synthesis pathways for these compounds have been defined, ensuring scalable production as the project advances towards more rigorous pharmacological testing. To further bolster the collaboration, Charnwood Discovery, a UK-based leader in drug discovery services, has been selected as the synthesis partner. Also, a new provisional patent was filed on August 27 with the US Patent and Trademark Office. For more insights into Graft Polymer's growth strategy and technological innovations, be sure to watch the full interview. Don’t forget to give the video a like, subscribe to the channel, and enable notifications for future content. #GraftPolymer #PolymerTechnology #Innovation #AnthonyTennyson #MaterialsScience #TechAdvancements #R&D #Sustainability #FutureOfMaterials #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
605 afleveringen
MP3•Thuis aflevering
Manage episode 436624057 series 2891889
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences. Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD). He noted that Awakn has successfully identified two aminoindane chemical series as lead candidates, marking a crucial step forward in drug development. These compounds show promise in improving treatment options for conditions like PTSD, which affects millions globally. Additionally, synthesis pathways for these compounds have been defined, ensuring scalable production as the project advances towards more rigorous pharmacological testing. To further bolster the collaboration, Charnwood Discovery, a UK-based leader in drug discovery services, has been selected as the synthesis partner. Also, a new provisional patent was filed on August 27 with the US Patent and Trademark Office. For more insights into Graft Polymer's growth strategy and technological innovations, be sure to watch the full interview. Don’t forget to give the video a like, subscribe to the channel, and enable notifications for future content. #GraftPolymer #PolymerTechnology #Innovation #AnthonyTennyson #MaterialsScience #TechAdvancements #R&D #Sustainability #FutureOfMaterials #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
605 afleveringen
Wszystkie odcinki
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.